Everything below concerns acetylated peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-12-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Lyophilized thymosin alpha 1 is typically stored refrigerated at 2 to 8 degrees Celsius and kept away from light. Reconstituted solutions are less stable and are usually used promptly after preparation. Repeated freeze-thaw cycles are avoided because they can promote aggregation and loss of activity. The peptide adsorbs to some plastic and glass surfaces, so a carrier protein is often added to dilute working solutions. Manufacturer instructions and published protocols both govern handling.
Identity and purity testing for thymosin alpha 1 relies mainly on reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatography separates the parent peptide from truncated or modified variants, while mass spectrometry confirms the expected molecular mass. Amino acid analysis and peptide mapping provide additional sequence confirmation. Counterion content, water content, and residual solvents are measured separately as part of specification testing. No single method captures every attribute, so laboratories combine several techniques.
The peptide lacks cysteine, methionine, and tryptophan, so disulfide scrambling and sulfur oxidation are not major degradation routes. Instead, aspartate residues can undergo isomerization or cyclization to succinimide intermediates, generating isoaspartate variants. Hydrolysis of peptide bonds also occurs slowly in solution. These changes may reduce biological activity even when the main peak remains detectable. Stability studies therefore track both potency and the appearance of related substances.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized powder | Reconstituted before use |
| Typical storage | 2-8 °C, protected from light | Applies to the powder |
| Reconstitution solvent | Sterile water or saline | Follow product labeling |
| Solution stability | Shorter than the powder | Refrigerate and use promptly |
| Primary purity method | Reversed-phase HPLC | Detects related substances |
胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明，它可促进未成熟T细胞向成熟T细胞分化，并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子，从而更有效地呈递抗原。此外，自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体，而是调节宿主免疫应答的强度与方向。
在信号层面，Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示，它能激活髓样分化因子88依赖的通路，进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答，有助于细胞免疫。然而，具体受体和结合位点尚未完全确定，不同实验模型的结果存在差异。
临床研究将Tα1用于慢性病毒感染、肿瘤辅助治疗和疫苗佐剂等场景。部分试验报告了免疫学指标改善，但临床终点获益在不同研究中并不一致。系统综述指出，研究间在人群、剂量和联合方案上差异较大，难以汇总结论。因此，Tα1的确切临床地位仍属开放问题，需要更多高质量随机对照试验来澄清。其机制研究也需从体外实验向体内模型推进。
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.
The peptide occurs naturally in thymic tissue and has been detected in serum and other biological fluids. Reported concentrations are low, and reliable measurement generally requires immunoassay or mass spectrometry with an enrichment step. It is released from a larger precursor, prothymosin alpha, by proteolytic cleavage, although the enzymes involved are not fully characterized. Whether circulating levels reflect thymic output specifically remains an open question.
==== Glioblastoma ==== As the most aggressive cancer originated in the brain, mutations found in patients with glioblastoma are related to the deletion of a part of the extracellular domain of the epidermal growth factor receptor (EGFR). This deletion causes CBL E3 ligase unable to bind to the receptor for its recycling and degradation via a ubiquitin-lysosomal pathway. Thus, EGFR is constitutively active in the cell membrane and activates its downstream effectors that are involved in cell proliferation and migration.
==== United States ==== Baptist, Edward (2016). The Half Has Never Been Told: Slavery and the Making of American Capitalism. Basic Books. ISBN 978-0-465-09768-5. Beckert, Sven; Rockman, Seth, eds. (2016). Slavery's Capitalism: A New History of American Economic Development. University of Pennsylvania Press. ISBN 978-0-8122-2417-7. Berlin, Ira (2009). Many Thousands Gone: The First Two Centuries of Slavery in North America. Harvard University Press. ISBN 978-0-674-02082-5. Berlin, Ira; Favreau, Marc; Miller, Steven (2011). Remembering Slavery: African Americans Talk About Their Personal Experiences of Slavery and Freedom. New Press. ISBN 978-1-59558-763-3. Blackmon, Douglas A. (2012). Slavery by Another Name: The re-enslavement of black americans from the civil war to World War Two. Icon Books Limited. ISBN 978-1-84831-413-9. Boles, John B. (2015). Black Southerners, 1619–1869. University Press of Kentucky. p. 3. ISBN 978-0-8131-5786-3. Engerman, Stanley Lewis (1999). Terms of Labor: Slavery, Serfdom, and Free Labor. Stanford, CA: Stanford University Press. ISBN 978-0-8047-3521-6. Genovese, Eugene D. (2011). Roll, Jordan, Roll: The World the Slaves Made. Knopf Doubleday Publishing Group. ISBN 978-0-307-77272-5. King, Richard H.; Genovese, Eugene (1977). "Marxism and the Slave South". American Quarterly. 29 (1): 117. doi:10.2307/2712264. ISSN 0003-0678. JSTOR 2712264. Mintz, S. "Slavery Facts & Myths". Digital History. Archived from the original on November 6, 2006. Morgan, Edmund Sears (1975). American Slavery, American Freedom: The Ordeal of Colonial Virginia.
== Children's future == In February 2020, a commission composed of the WHO, UNICEF, and The Lancet published a report of the investigation of the impact of two existential threats to children's health, the climate emergency and predatory commercial exploitation. It ranked 180 nations according to the steps taken by each to blunt these threats to the well-being of their children. Thailand ranked 64 of 180 nations (1=best). Eight other ASEAN nations were ranked: Singapore, 12; Malaysia, 44; Vietnam, 58; Philippines, 110; Cambodia, 114; Indonesia, 117; Myanmar, 120; Laos, 137.
There are few native natural predators of adult emus still extant. Early in its species history it may have faced numerous terrestrial predators now extinct, including the giant lizard Megalania, the thylacine, and possibly other carnivorous marsupials, which may explain their seemingly well-developed ability to defend themselves from terrestrial predators. The main predator of emus today is the dingo, which was originally introduced by Aboriginals thousands of years ago from a stock of semi-domesticated wolves. Dingoes try to kill the emu by attacking the head. The emu typically tries to repel the dingo by jumping into the air and kicking or stamping the dingo on its way down. The emu jumps as the dingo barely has the capacity to jump high enough to threaten its neck, so a correctly timed leap to coincide with the dingo's lunge can keep its head and neck out of danger. Despite the potential prey-predator relationship, the presence of predaceous dingoes does not appear to heavily influence emu numbers, with other natural conditions just as likely to cause mortality. Wedge-tailed eagles are the only avian predator capable of attacking fully-grown emus, though are perhaps most likely to take small or young specimens. The eagles attack emus by swooping downwards rapidly and at high speed and aiming for the head and neck. In this case, the emu's jumping technique as employed against the dingo is not useful. The birds try to target the emu in the open ground so that it cannot hide behind obstacles.
Sources: en.wikipedia.org
Among those who send their children to public schools, they favor policies that ensure the high quality of such schools with exclusionary admissions and zoning ordinances. Said parents also hire nannies and housekeepers to reduce the time they spend doing house chores so that they can more time on culturally and educationally enriching activities with their children. In fact, the amount of time parents spend with their children has gone up since the mid-1960s, especially among educated couples. An early start to the accumulation of cultural capital helps children stand out from the competition as they mature, making them more likely to be admitted to prestigious universities. On the other hand, Generation Z typically grows up with less independence than the Baby Boomers or Generation X. This constant supervision of children by their parents—protective or "helicopter parenting"—is partly due to concerns over public safety or legal requirements and partly due to the fact that many educators and parents view play as outdated and irrelevant. As a result, a portion of this cohort spends much of their leisure in doors rather than outside, with little to no adult supervision. In reality, the United States has become a safer place for children, who are much less likely to be abducted or otherwise harmed by an adult than ever before. In 2018, the American Academy of Pediatrics released a statement emphasizing the importance of unstructured time spent by children pointing to the benefits for children's social, cognitive, and language skills development.
=== Serious adverse event reconciliation === The CRF collects adverse events reported during the conduct of the clinical trial however there is a separate process which ensures that serious adverse events are reported quickly. The clinical data manager must ensure that data is reconciled between these processes.
Proton-transfer-reaction mass spectrometry (PTR-MS) is an analytical chemistry technique that uses gas phase hydronium reagent ions which are produced in an ion source. PTR-MS is used for online monitoring of volatile organic compounds (VOCs) in ambient air and was developed in 1995 by scientists at the Institut für Ionenphysik at the Leopold-Franzens University in Innsbruck, Austria. A PTR-MS instrument consists of an ion source that is directly connected to a drift tube (in contrast to SIFT-MS no mass filter is interconnected) and an analyzing system (quadrupole mass analyzer or time-of-flight mass spectrometer). Commercially available PTR-MS instruments have a response time of about 100 ms and reach a detection limit in the single digit pptv or even ppqv region. Established fields of application are environmental research, food and flavor science, biological research, medicine, security, cleanroom monitoring, etc.
Sources: en.wikipedia.org
The structure of somatostatin receptor antagonists is similar to that of the agonists. Some agonists were already approved by the FDA for clinical use, such as In-DTPA-octreotide and Ga-DOTATATE. Development started after the discovery of modifications that can be done to the octreotide group, an ssrt selective subtype agonist, to cause its agonistic effects to be lost and gain antagonistic effects. Different subtype receptor antagonists were later developed. Research has been done mostly on the sstr2 receptor antagonist, as the sstr2 receptor is expressed on most tumors. Somatostatin receptor antagonists are divided by generation based on the type of the subtype receptor antagonist. The first generation consists of sst2-ANT and BASS, which are sstr2 selective; and sst3-ODAN-8, which is selective for sstr3. After initial results of their increased sensitivity to neurocrine tumors appeared, ssrt2 selective antagonists that had even higher affinity were developed. These were LM3, JR10, and JR11, which make up the second generation. JR11 was shown to be the most effective among these 3 antagonists, and compounds that entered further clinical development to act as a PET imaging agent or therapeutic agent carried this subtype antagonist. The presence of a chelator coupled to the subtype antagonist was shown to affect the biological properties., by increasing the binding stability of the radionuclide to the rest of the compound, and increasing the binding affinity to the receptor by allowing conjugation of the radionuclide to the receptor.
The first docking of Soviet spacecraft was finally realized in January 1969 by the Soyuz 4 and Soyuz 5 missions. It was the first-ever docking of two crewed spacecraft, and the first transfer of crew from one space vehicle to another.
==== Fatty acids ==== There has been a growing interest in the role of long-chain omega-3 polyunsaturated fatty acids to reduce inflammation and alleviate the symptoms of RA. Metabolism of omega-3 polyunsaturated fatty acids produces docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which inhibit pro-inflammatory eicosanoids and cytokines (TNF-a, IL-1b, and IL-6), decreasing both lymphocyte proliferation and reactive oxygen species. These studies showed evidence for significant clinical improvements on RA in inflammatory status and articular index. Gamma-linolenic acid, an omega-6 fatty acid, may reduce pain, tender joint count, and stiffness, and is generally safe. For omega-3 polyunsaturated fatty acids (found in fish oil, flax oil and hemp oil), a meta-analysis reported a favorable effect on pain, although confidence in the effect was considered moderate. The same review reported less inflammation but no difference in joint function. A review examined the effect of marine oil omega-3 fatty acids on pro-inflammatory eicosanoid concentrations; leukotriene4 (LTB4) was lowered in people with rheumatoid arthritis but not in those with non-autoimmune chronic diseases. Fish consumption has no association with RA. A fourth review limited inclusion to trials in which people eat ≥2.7 g/day for more than three months. The use of pain relief medication was decreased, but improvements in tender or swollen joints, morning stiffness, and physical function were unchanged.
Sources: en.wikipedia.org
The lyophilized powder is kept refrigerated at 2 to 8 degrees Celsius and protected from light. Reconstituted solutions should be used promptly. Freezing and thawing repeatedly is avoided.
Reversed-phase HPLC is the primary tool for purity, paired with mass spectrometry for identity. Amino acid analysis and peptide mapping add sequence confirmation. Several techniques are combined because no single test covers every attribute.
It lacks sulfur-containing residues, so oxidation is limited. Aspartate isomerization and slow hydrolysis are the main concerns. Solution stability is shorter than that of the lyophilized powder.
It is usually described as an immunomodulatory peptide rather than a classic circulating hormone. No endocrine gland is known to release it as a primary secretory product, and its measured presence in blood is not firmly established.